Advancing Sustainable Packaging - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Advancing Sustainable Packaging
MeadWestvaco is recognized at CPhI for its sustainable pharmaceutical packaging.


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 8, Issue 12

The marriage of sustainability and innovation provides for a potent combination in new product demand. As in all product development, improving or creating new products to meet evolving customer needs is crucial for success. That function is further enhanced when it also satisfies sustainability concerns, a benefit for consumers as well as producers in potentially achieving improved costs and performance.

A recent example is a pharmaceutical packaging solution, Shellpak Renew, developed by MeadWestvaco (MWW), which received the Best Sustainable Pharmaceutical Packaging award at CPhI Worldwide, which was held in Madrid in October. Shellpak® Renew is an environmentally friendly medication-adherence packaging solution.

Shellpak Renew was adapted based on customer research to deliver key patient improvements: decreased weight and size, including an environmentally friendly, curbside recyclable outer carton. Launched in April of this year, Shellpak Renew is part of MWV’s efforts to provide solutions for poor medication adherence. Shellpak Renew contains color-coded spine labels to help distinguish among drugs, easy-open, child-resistant push buttons, and an integrated calendar that helps patients track medication usage. Additionally, it provides a 40% weight-reduction compared with the company’s original Shellpak packaging and has an outer carton made of Natralock, an environmentally friendly paperboard that maximizes the use of recyclable materials and minimizes waste.

This year marked the introduction of the Best Sustainable Packaging award category of the CPhI Pharma Awards. The award recognizes companies that provide excellence in delivering a specific material, process or piece of equipment that enables pharmaceutical companies to achieve a more sustainable package or process.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here